It was announced today (18 October) that Dr Sarah Teichmann and her group will join the Cambridge Stem Cell Institute (CSCI)
Sarah will be moving from the Wellcome Sanger Institute, where she has been heading the Cellular Genetics programme. Sarah is a highly distinguished computational biologist, and co-lead of the international Human Cell Atlas initiative, a global research community with over 3,000 members.
CSCI Director Bertie Göttgens says, “I am particularly excited by Sarah’s vision whereby future Human Cell Atlas research should embrace the elucidation of tissue and organ function, which is perfectly aligned with the mission of our Wellcome-funded Tissue Scale Biology Discovery Research Platform.”
Within CSCI, Sarah’s group will also continue their innovative studies using in vitro models and ex vivo culture of the human thymus, which will provide many exciting interfaces and synergistic opportunities. Sarah’s work on T-cell development and function will also further strengthen synergies and collaborations with our neighbours in CITIID as well as the wider Department of Medicine, which will provide dedicated space for primary patient sample handling and processing within the main Addenbrooke’s research block.
Sarah is a fellow of the Royal Society and Academy of Medical Sciences, has received many prizes and accolades, and has championed the careers of researchers from a wide range of backgrounds.
Sarah Teichmann says, “I am incredibly excited to be moving to the Cambridge Biomedical Campus with my group joining CSCI and the Department of Medicine, which will open up new opportunities to use our Human Cell Atlas discoveries as a reference for patient disease samples as well as a reference for cell and tissue engineering.”